CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL

Journal of Immunology

Volumn 185, Issue 7, 2010, Pages 3788-3799

  Boise, Lawrence H ^a,b   Minn, Andy J ^a,b   Noel, Patricia J ^b   June, Carl H ^c   Accavitti, Mary Ann ^d   Lindsten, Tullia ^a,b   Thompson, Craig B ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c NAVAL MEDICAL RESEARCH INSTITUTE   (United States)

^d University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD3 ANTIBODY; FAS ANTIGEN; INTERLEUKIN 2; PROTEIN BCL 2; PROTEIN BCL XL; T LYMPHOCYTE RECEPTOR; PROTEIN BCL X;

APOPTOSIS; ARTICLE; CELL DEATH; CELL PROTECTION; CELL SURVIVAL; CROSS LINKING; CYTOKINE PRODUCTION; GAMMA IRRADIATION; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; IN VITRO STUDY; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; HISTORY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM;

ALLERGY AND IMMUNOLOGY; ANTIGENS, CD28; BCL-X PROTEIN; CELL SURVIVAL; GENE EXPRESSION; GENE EXPRESSION REGULATION; HISTORY, 20TH CENTURY; HUMANS; LYMPHOCYTE ACTIVATION; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 77958150055     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Bierer, B. E., and Burakoff, S. J. (1991). T cell receptors: adhesion and signaling. Adv. Cancer Res. 56, 49-76.
2. Boise, L. H., Gonzalez-Garcia, M., Postema, C. E., Ding, L., Lindsten, T., Turka, L. A., Mao, X., Nunez, G., and Thompson, C. B. (1993). bcl-x, a bc/-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74, 597-608.
3. Chen, L., Ashe, S., Brady, W. A., Hellstrom, I., Hellstrom, K. E., Ledbetter, J. A., McGowan, P., and Linsley, P. S. (1992). Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 71, 1093-1102.
4. Chleq-Deschamps, C. M., Le Brun, D. P., Huie, P., Besnier, D. P., Warnke, R. A., Sibley, R. K., and Cleary, M. L. (1993). Topographical dissociation of BCL-2 messenger RNA and protein expression in human lymphoid tissues. Blood 81, 293-298.
5. Fraser, J. D., Irving, B. A., Crabtree, G. R., and Weiss, A. (1991). Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science 251, 313-316.
6. Gillis, S., and Smith, K. A. (1977). Long term culture of tumor-specific cytotoxic T cells. Nature 268, 154-156.
7. Gimmi, C. D., Freeman, G. J., Gribben, J. G., Sugita, K., Freedman, A. S., Morimoto, C., and Nadler, L. M. (1991). B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2. Proc. Natl. Acad. Sci. USA 88, 6575-6579.
8. Graninger, W. B., Seto, M., Boutain, B., Goldman, P., and Korsmeyer, S. J. (1987). Expression of bcl-2 and bcl2-lg fusion transcripts in normal and neoplastic cells. J. Clin. Invest. 80, 1512-1515.
9. Groux, H., Monte, D., Plouvier, B., Capron, A., and Ameisen, J.-C. (1993). CD3-mediated apoptosis of human medullary thymocytes and activated peripheral T cells: respective roles of interleukin-1, interleukin-2, interferon-γ and accessory cells. Eur. J. Immunol. 23, 1623-1629.
10. Harding, F. A., McArthur, J. G., Gross, J. A., Raulet, D. H., and Allison, J. P. (1992). CD28-mediated signaling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 356, 607-609.
11. Hockenbery, D., Nuñez, G., Milliman, C., Schreiber, R. D., and Korsmeyer, S. J. (1990). Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348, 334-336.
12. June, C. H., Ledbetter, J. A., Gillespie, M. M., Lindsten, T., and Thompson, C. B. (1987). T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression. Mol. Cell. Biol. 7, 4472-4481.
13. June, C. H., Bluestone, J. A., Nadler, L. M., and Thompson, C. B. (1994). The B7 and CD28 receptor families. Immunol. Today 15, 321-331.
14. + T cells in mice tolerant to Staphylococcus aureus enterotoxin B. Nature 349, 245-248.
15. + antigen-presenting cells. Int. Immunol. 4, 1381-1388.
16. Kearney, J. F. (1984). Hybridomas and monoclonal antibodies. In Fundamental Immunology. W. E. Paul, editor. (New York: Raven Press), pp. 751-766.
17. Klas, C., Debatin, K.-M., Jonker, R. R., and Krammer, P. H. (1993). Activation interferes with the APO-1 pathway in mature human T cells. Int. Immunol. 5, 625-630.
18. Lenschow, D. J., Zeng, Y., Thistlethwaite, J. R., Montag, A., Brady, W., Gibson, M. G., Linsley, P. S., and Bluestone, J. A. (1992). Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg. Science 257, 789-792.
19. Lindsten, T., June, C. H., Ledbetter, J. A., Stella, G., and Thompson, C. B. (1989). Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 244, 339-343.
20. Linsley, P. S., and Ledbetter, J. A. (1993). The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11, 191-212.
21. Lowenthal, J. W., and Harris, A. W. (1985). Activation of mouse lymphocytes inhibits induction of rapid cell death by X-irradiation. J. Immunol. 735, 1119-1125.
22. Miyawaki, T., Uehara, T., Nibu, R., Tsuji, T., Yachie, A., Yonehara, S., and Taniguchi, N. (1992). Differential expression of apoptosisrelated Fas antigen on lymphocyte subpopulations in human peripheral blood. J. Immunol. 149, 3753-3758.
23. Nakayama, K.-L., Nakayama, K., Negishi, I., Kuida, K., Shinkai, Y., Louie, M. C., Fields, L. E., Lucas, P. J., Stewart, V., Alt, F. W., and Loh, D. Y. (1993). Disappearance of the lymphoid system in Bcl-2 homozygous mutant chimeric mice. Science 261, 1584-1588.
24. Nuñez, G., London, L., Hockenbery, D., Alexander, M., McKearn, J. P., and Korsmeyer, S. J. (1990). Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J. Immunol. 144, 3602-3610.
25. Oltvai, Z. N., Milliman, C. L., and Korsmeyer, S. J. (1993). Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death. Cell 74, 609-619.
26. Reed, J. C., Tsujimoto, Y., Alpers, J. D., Croce, C. M., and Nowell, P. C. (1987). Regulation of bcl-2 proto-oncogene expression during normal human lymphocyte proliferation. Science 236, 1295-1299.
27. Reed, J. C., Miyashita, T., Cuddy, M., and Cho, D. (1992). Regulation of p26-Bcl-2 protein levels in human peripheral blood lymphocytes. Lab. Invest. 67, 443-449.
28. Schrek, R., and Stefani, S. (1964). Radioresistance of phytohemagglutinin-treated normal and leukemic lymphocytes. J. Natl. Cancer Inst. 32, 507-521.
29. Schwartz, R. H. (1990). A cell culture model for T lymphocyte clonal anergy. Science 248, 1349-1356.
30. Shi, Y., Sahai, B. M., and Green, D. R. (1989). Cyclosporin A inhibits activation-induced cell death in T-cell hybridomas and thymocytes. Nature 339, 625-626.
31. Springer, T. A., Dustin, M. L., Kishimoto, T. K., and Marlin, S. D. (1987). The lymphocyte function-associated LFA-1, CD2, and LFA-3 molecules: cell adhesion receptors of the immune system. Annu. Rev. Immunol. 5, 223-252.
32. Stewart, C. C., Stevenson, A. P., and Habbersett, R. C. (1988). The effect of low-dose irradiation on unstimulated and PHA-stimulated human lymphocyte subsets. Int. J. Radiat. Biol. 53, 77-87.
33. Thompson, C. B., Lindsten, T., Ledbetter, J. A., Kunkel, S. L., Young, H. A., Emerson, S. G., Leiden, J. M., and June, C. H. (1989). CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/ cytokines. Proc. Natl. Acad. Sci. USA 86, 1333-1337.
34. + T cells by B7-transfected melanoma cells. Science 259, 368-370.
35. Turka, L. A., Linsley, P. S., Lin, H., Brady, W., Leiden, J. M., Wei, R.-Q., Gibson, M. L., Zheng, X.-G., Myrdal, S., Gordon, D., Bailey, T., Boiling, S. F., and Thompson, C. B. (1992). T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc. Natl. Acad. Sci. USA 89, 11102-11105.
36. Ucker, D. S., Ashwell, J. D., and Nickas, G. (1989). Activation-driven T cell death. I. Requirements for de novo transcription and translation and association with genomic fragmentation. J. Immunol. 143, 3461-3469.
37. Veis, D. J., Sorenson, C. M., Shutter, J. R., and Korsmeyer, S. J. (1993a). Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75, 229-240.
38. Veis, D. J., Sentman, C. L., Bach, E. A., and Korsmeyer, S. J. (1993b). Expression of the Bcl-2 protein in murine and human thymocytes and in peripheral T lymphocytes. J. Immunol. 757, 2546-2554.
39. Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A., and Nagata, S. (1992). Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356, 314-317.
40. Webb, S., Morris, C., and Sprent, J. (1990). Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity. Cell 63, 1249-1256.